Crimean-Congo hemorrhagic fever treated with ribavirin in a pregnant woman.
We report a case of Crimean-Congo Hemorrhagic Fever (CCHF) infection in a 36-week pregnant woman. She was treated with ribavirin. She did not transmit the disease to her baby. Her baby was the first known to survive being delivered by a woman with CCHF. The initialization of ribavirin treatment probably resulted in the survival of the mother and her baby.
Dizbay
Murat
M
Department of Clinical Microbiology and Infectious Diseases, Gazi University School of Medicine, Besevler, 06500 Ankara, Turkey. muratdizbay@gazi.edu.tr
Aktas
Firdevs
F
Gaygisiz
Ummugulsum
U
Ozger
Hasan Selcuk
HS
Ozdemir
Kevser
K
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006479:Hemorrhagic Fever, Crimean / Q000188:drug therapy*; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D012254:Ribavirin / Q000627:therapeutic use*; D055815:Young Adult
D000998:Antiviral Agents; D012254:Ribavirin